Clinical Trial Update: Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers [Phase 3]

View source ↗

Summary

Phase 3 trial assessing immunogenicity and safety of a meningococcal conjugate vaccine given concomitantly with other vaccines in toddlers; results posted after…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Meningitis

Drugs mentioned

• Meningococcal conjugate vaccine (Meningococcal conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2020-06-09